Results 21 to 30 of about 4,754 (217)

Hoigne Syndrome Caused by Intralesional Meglumine Antimoniate. [PDF]

Open Access Maced J Med Sci, 2017
Hoigne syndrome (HS) is the term coined to describe an acute, non-allergic, psychiatrically based reaction occurring with a wide list of medications, mainly antibiotics. Since its first description by Hoigne and Schoch in 1959, few cases have been reported in medical literature and, although antimicrobials are commonly used, very rarely in dermatology.
Guarneri C, Tchernev G, Wollina U, Lotti T.   +3 more
europepmc   +6 more sources

Successful treatment of cutaneous leishmaniasis with intralesional meglumine antimoniate: A case series

Revista da Sociedade Brasileira de Medicina Tropical, 2019
Cutaneous leishmaniasis (CL) is a high-morbidity, vector-borne disease endemic to Colombia. Unlike conventional systemic antileishmanial therapy, intralesional meglumine antimoniate administration has fewer adverse effects and can be as effective and ...
Margarita Arboleda, Santiago Barrantes, Luz Yaned Úsuga, Sara María Robledo   +3 more
doaj   +1 more source

Follow-up monitoring in a cat with leishmaniosis and coinfections with Hepatozoon felis and ‘Candidatus Mycoplasma haemominutum’ [PDF]

, 2017
Case summary A 6-year-old female neutered domestic shorthair cat from Cyprus was presented with multiple ulcerated skin nodules. Cytology and histopathology of the lesions revealed granulomatous dermatitis with intracytoplasmic organisms, consistent ...
Attipa, C, Baneth, G, Brooks-Brownlie, H, Martínez-Orellana, P, Nachum-Biala, Y, Neofytou, K, Solano-Gallego, L, Tasker, S, Yiapanis, C   +8 more
core   +7 more sources

Pharmacometabolomics of Meglumine Antimoniate in Patients With Cutaneous Leishmaniasis. [PDF]

Front Pharmacol, 2019
Le contrôle de la leishmaniose cutanée (CL) dans les Amériques dépend de la chimiothérapie avec des antimoniaux pentavalents parentéraux. Des taux élevés d'échec thérapeutique incitent à rechercher des marqueurs prédictifs et pronostiques de la réactivité thérapeutique.
Vargas DA, Prieto MD, Martínez-Valencia AJ, Cossio A, Burgess KEV, Burchmore RJS, Gómez MA.   +6 more
europepmc   +7 more sources

susceptibility to pentavalent antimony in strains is not modified during or passages but is modified after host treatment with meglumine antimoniate [PDF]

, 2002
Background: Leishmaniasis is a common parasitic disease in Southern Europe, caused by Leishmania infantum. The failures of current treatment with pentavalent antimonials are partially attributable to the emergence of antimony-resistant Leishmania strains.
Carrió Díaz-Meco, Jaume, Portús Vinyeta, Montserrat   +1 more
core   +3 more sources

Pharmacokinetics of Antimony in Children Treated for Leishmaniasis with Meglumine Antimoniate [PDF]

The Journal of Infectious Diseases, 2007
In some settings, the response to pentavalent antimonial therapy for leishmaniasis may be lower in children than in adults. We hypothesized that there are age-dependent pharmacokinetic differences of potential clinical relevance.We compared the pharmacokinetics of antimony (Sb) in adults and 2 groups of children 3-6 years old who had cutaneous ...
Cruz, Adriana Taveira da UNIFESP, Rainey, Petrie M., Herwaldt, Barbara L., Stagni, Grazia, Palacios, Ricardo, Trujillo, Rodolfo UNIFESP, Saravia, Nancy G.   +6 more
openaire   +3 more sources

In Vitro Reduced Susceptibility to Pentavalent Antimonials of a Leishmania infantum Isolate from a Human Cutaneous Leishmaniasis Case in Central Italy

Microorganisms, 2021
Cutaneous leishmaniasis (CL) caused by Leishmania (Leishmania) infantum is endemic in the Mediterranean basin. Here we report an autochthonous case of CL in a patient living in central Italy with an unsatisfactory response to treatment with intralesional
Aurora Diotallevi, Gloria Buffi, Giovanni Corbelli, Marcello Ceccarelli, Margherita Ortalli, Stefania Varani, Mauro Magnani, Luca Galluzzi   +7 more
doaj   +1 more source

American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis resistant to meglumine antimoniate, but with good response to pentamidine: a case report

Revista da Sociedade Brasileira de Medicina Tropical, 2011
This is a case report of a Brazilian soldier with cutaneous leishmaniasis. The lesion relapsed following two systemic treatments with meglumine antimoniate.
Maria Inês Fernandes Pimentel, Cibele Baptista, Évelyn Figueiredo Rubin, Érica de Camargo Ferreira e Vasconcellos, Marcelo Rosandiski Lyra, Mariza de Matos Salgueiro, Maurício Naoto Saheki, Cláudia Maria Valete Rosalino, Maria de Fátima Madeira, Aline Fagundes da Silva, Eliame Mouta Confort, Armando de Oliveira Schubach   +11 more
doaj   +1 more source

Comparison of Oral Zinc Sulfate with Systemic Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis

Dermatology Research and Practice, 2011
The purpose of this study was to investigate comparison between oral zinc sulfate and meglumine antimoniate in the treatment of cutaneous leishmaniasis (CL). So 100 patients with CL were included and randomly divided into two groups.
Mohamad Javad Yazdanpanah, Mahnaz Banihashemi, Fakhrozaman Pezeshkpoor, Mohammad Khajedaluee, Sororozaman Famili, Iman Tavakoli Rodi, Hadis Yousefzadeh   +6 more
doaj   +1 more source

Coinfection of Leishmania (Viannia) braziliensis and Streptococcus pneumoniae in multiple cutaneous lesions [PDF]

, 2016
Key learning points Cutaneous leishmaniasis is the most common clinical disease caused by all the Leishmania species that are pathogenic to humans. Other bacterial coinfections of Leishmania lesions have been described, but this is the first report of ...
Chiapello, Laura Silvina, Cortes, Paulo R., De Petris, Carlos, Dib, David, Echenique, Jose Ricardo, Herrero, Mónica V., Nuncira, Carmen T.   +6 more
core   +2 more sources